Bernard Coulie, President and CEO at PLIANT THERAPEUTICS, INC. (PLRX), sold 79,779 shares at $35.42 ($2.8M) on 2023-01-27, disclosed to the SEC on 2023-01-27.
Open-market sale of $2.8M PLRX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.10 | 15,000 | $527K | 18.7% |
| 2 | $35.29 | 15,000 | $529K | 18.8% |
| 3 | $35.09 | 9,779 | $343K | 12.2% |
| 4 | $35.09 | 9,779 | $343K | 12.2% |
| 5 | $35.42 | 8,698 | $308K | 10.9% |
| 6 | $35.42 | 8,698 |
| $308K |
| 10.9% |
| 7 | $36.06 | 6,302 | $227K | 8.1% |
| 8 | $36.06 | 6,302 | $227K | 8.1% |
| 9 | $36.64 | 221 | $8K | 0.3% |
| Total | $35.36 avg | 79,779 | $2.8M | 100% |
| Filing → |
| PLRX | SELL | 2024-07-12 | $895K | — | Filing → |
| PLRX | SELL | 2024-01-19 | $886K | — | Filing → |
| PLRX | SELL | 2023-07-19 | $2.5M | — | Filing → |